3.4. Ob-NAFLD Selectively Modulates Renal Antioxidant Enzymes, and Metformin Differentially Affects GST-P, SOD1, and SOD2 Levels. The gene discussed is SOD2; the disease is metabolic dysfunction-associated steatotic liver disease.